ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
of 4,772 shares of common stock in an open-market transaction on March 11, 2026, according to a SEC Form 4 filing Transaction summary Metric Value Shares sold (direct) Transaction value Post-transaction shares (direct) Post-transaction value (direct ownership) $2.95 million Transaction value based on SEC Form 4 reported price ($74.91). Key questions How does the scale of this transaction compare to recent insider sales? Rowland has one other sale on record, in August, when he disposed of 4,975 shares. What is the impact of this sale on Rowland Thomas Andrew's direct ownership stake? Direct common stock holdings decreased by 11%, leaving a post-transaction balance of 38,730 shares; no indirect holdings or derivative positions were reported. How does the transaction price compare to current market levels? The sale was executed at $74.91 per share, which is approximately 3.8% above the current price of $72.17 as of March 17, 2026. Company overview Metr
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease [Yahoo! Finance]Yahoo! Finance
- 3 Reasons ANIP is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals Expands Ophthalmology Reach As Valuation Signals Upside Potential [Yahoo! Finance]Yahoo! Finance
- Sizing Up ANI Pharmaceuticals (ANIP) After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals, Inc. (ANIP) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
ANIP
Earnings
- 2/27/26 - Beat
ANIP
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/13/26 - Form 4
- 3/13/26 - Form 4
- ANIP's page on the SEC website